rs28932177

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_022455.5(NSD1):​c.2071G>A​(p.Ala691Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0246 in 1,614,110 control chromosomes in the GnomAD database, including 608 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A691A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.018 ( 32 hom., cov: 32)
Exomes 𝑓: 0.025 ( 576 hom. )

Consequence

NSD1
NM_022455.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.462

Publications

23 publications found
Variant links:
Genes affected
NSD1 (HGNC:14234): (nuclear receptor binding SET domain protein 1) This gene encodes a protein containing a SET domain, 2 LXXLL motifs, 3 nuclear translocation signals (NLSs), 4 plant homeodomain (PHD) finger regions, and a proline-rich region. The encoded protein enhances androgen receptor (AR) transactivation, and this enhancement can be increased further in the presence of other androgen receptor associated coregulators. This protein may act as a nucleus-localized, basic transcriptional factor and also as a bifunctional transcriptional regulator. Mutations of this gene have been associated with Sotos syndrome and Weaver syndrome. One version of childhood acute myeloid leukemia is the result of a cryptic translocation with the breakpoints occurring within nuclear receptor-binding Su-var, enhancer of zeste, and trithorax domain protein 1 on chromosome 5 and nucleoporin, 98-kd on chromosome 11. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Sep 2018]
NSD1 Gene-Disease associations (from GenCC):
  • Beckwith-Wiedemann syndrome due to NSD1 mutation
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Sotos syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
  • Sotos syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0032784045).
BP6
Variant 5-177210470-G-A is Benign according to our data. Variant chr5-177210470-G-A is described in ClinVar as Benign. ClinVar VariationId is 159279.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0182 (2778/152266) while in subpopulation NFE AF = 0.0282 (1919/68008). AF 95% confidence interval is 0.0272. There are 32 homozygotes in GnomAd4. There are 1334 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 2778 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NSD1NM_022455.5 linkc.2071G>A p.Ala691Thr missense_variant Exon 5 of 23 ENST00000439151.7 NP_071900.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NSD1ENST00000439151.7 linkc.2071G>A p.Ala691Thr missense_variant Exon 5 of 23 1 NM_022455.5 ENSP00000395929.2

Frequencies

GnomAD3 genomes
AF:
0.0183
AC:
2781
AN:
152148
Hom.:
32
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00444
Gnomad AMI
AF:
0.0296
Gnomad AMR
AF:
0.00831
Gnomad ASJ
AF:
0.00980
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0269
Gnomad FIN
AF:
0.0302
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0282
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.0205
AC:
5162
AN:
251228
AF XY:
0.0215
show subpopulations
Gnomad AFR exome
AF:
0.00501
Gnomad AMR exome
AF:
0.00766
Gnomad ASJ exome
AF:
0.0142
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0309
Gnomad NFE exome
AF:
0.0263
Gnomad OTH exome
AF:
0.0212
GnomAD4 exome
AF:
0.0253
AC:
36996
AN:
1461844
Hom.:
576
Cov.:
38
AF XY:
0.0255
AC XY:
18578
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.00349
AC:
117
AN:
33480
American (AMR)
AF:
0.00821
AC:
367
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0142
AC:
371
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.0299
AC:
2576
AN:
86258
European-Finnish (FIN)
AF:
0.0310
AC:
1657
AN:
53410
Middle Eastern (MID)
AF:
0.0333
AC:
192
AN:
5768
European-Non Finnish (NFE)
AF:
0.0274
AC:
30434
AN:
1111974
Other (OTH)
AF:
0.0212
AC:
1282
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
2150
4300
6449
8599
10749
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1102
2204
3306
4408
5510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0182
AC:
2778
AN:
152266
Hom.:
32
Cov.:
32
AF XY:
0.0179
AC XY:
1334
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.00443
AC:
184
AN:
41546
American (AMR)
AF:
0.00830
AC:
127
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00980
AC:
34
AN:
3468
East Asian (EAS)
AF:
0.000579
AC:
3
AN:
5180
South Asian (SAS)
AF:
0.0267
AC:
129
AN:
4828
European-Finnish (FIN)
AF:
0.0302
AC:
321
AN:
10622
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0282
AC:
1919
AN:
68008
Other (OTH)
AF:
0.0128
AC:
27
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
142
284
427
569
711
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0239
Hom.:
183
Bravo
AF:
0.0151
TwinsUK
AF:
0.0272
AC:
101
ALSPAC
AF:
0.0244
AC:
94
ESP6500AA
AF:
0.00635
AC:
28
ESP6500EA
AF:
0.0241
AC:
207
ExAC
AF:
0.0209
AC:
2534
Asia WGS
AF:
0.0150
AC:
53
AN:
3478
EpiCase
AF:
0.0276
EpiControl
AF:
0.0219

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 25, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28146470) -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jun 29, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Sotos syndrome Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.066
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.42
CADD
Benign
16
DANN
Benign
0.97
DEOGEN2
Benign
0.052
.;T;.
Eigen
Benign
-0.52
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.44
N
LIST_S2
Benign
0.80
T;T;.
MetaRNN
Benign
0.0033
T;T;T
MetaSVM
Benign
-0.76
T
MutationAssessor
Benign
1.2
.;L;.
PhyloP100
0.46
PrimateAI
Benign
0.27
T
PROVEAN
Benign
0.22
N;N;N
REVEL
Benign
0.20
Sift
Benign
0.21
T;T;T
Sift4G
Benign
0.46
T;T;T
Polyphen
0.0060
B;B;B
Vest4
0.056
MPC
0.054
ClinPred
0.0027
T
GERP RS
3.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.028
gMVP
0.14
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28932177; hg19: chr5-176637471; COSMIC: COSV61770811; COSMIC: COSV61770811; API